Error loading player: No playable sources found
89866
CASSS Welcome & CGTP 2024 Introduction
Date
June 11, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Session Chairs
General
Tracks
Related Products
Plenary Session 7 - Streamlining AAV Vector-based Gene Therapy Development Through the Utilization of Manufacturing and Analytical Platform Approaches
Our ability to treat diseases previously untreatable through the delivery of adeno-associated virus (AAV)-based gene therapies has been a tremendous advancement in pharmaceutical development…
Parallel Session 2 - How to Control Off Target Genotoxicity for Genome and Epigenome Editing Medicines
Genome editing is a tool that enables a new generation of medicines by directly targeting with high precision the genetic cause of a disease. It also allows for immune evasion and prevents microenvironment responses: concepts vital to more potent, off the shelf, cell, and gene therapies…
Hot Topic Session - ICH Cell & Gene Therapy Discussion Group Updates
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) brings together regulatory authorities and representatives from the pharmaceutical industry from across the globe to discuss a range of technical and scientific considerations for medicinal…
Parallel Session 3 - Viral Vector-based Gene Therapy Products
The field of Cell and Gene Therapy has witnessed expanding numbers of regulatory approvals in recent years…
